Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ACHV Achieve Life Sciences Inc

3,61

0,00 (0,00%)

31 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Dez 2024 bis Dez 2024

Click Here for more Achieve Life Sciences Charts.

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Achieve Life Sciences Charts.

News Achieve Life Sciences Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 9 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 9 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 9 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 9 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Montag 9 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 5 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
Dienstag 3 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Achieve Life Sciences Inc News-Artikel

Heritage Commerce

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen